Archived Events

Please see also archived presentations from Methods Core Seminars.

Tuesday, May 31st, 2016

CAPS Communty Town Hall presents Andrew Reynolds: Sex-C: A Potential Research Agenda for Understanding Sexual Transmission of Hepatitis C

While the overall risk of sexual transmission of HCV is comparatively low, risk of transmission is much higher for HIV-infected persons and MSM.  The implications for prevention of both primary infection and re-infection are profound, and more work and research is needed to better understand this problem.

This presentation will cover sexual transmission of HCV, discuss strategies for health education and risk reduction counseling, and give some examples of educational materials for both providers and patients.  We’ll present a research strategy to look at sexual transmission of HCV and suggest next steps and possible roles for CAPS research.

Andrew Reynolds in the Hepatitis C Education Manager at Project Inform.  He writes health education materials, fact sheets and articles on all aspects of hepatitis C awareness, prevention and treatment.  He is the author of the Positively Aware “Annual Hepatitis C Drug Guide,” and serves on the AASLD/IDSA HCV Guidance Panel.  Andrew writes and lectures extensively on sexual transmission of HCV.  He developed the Hepatitis C Screening Toolkit for HIV Providers, and a soon-to-be-published booklet entitled “Sexual Transmission of Hepatitis C: Tips for Gay Men.”

Andrew is a member of CAPS Community Advisory Board.

12:00pm-1:00pm. 3rd Floor – Room 3700, Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94143

Portrait photo of Andrew Reynolds, Hepatitis C Education Manager at Project Inform and CAPS Community Advisory Board Member

Tuesday, May 17th, 2016

CAPS Methods Core Presents a Joint Methods/TAPS Postdoctoral Session

Title: Social Network Data Collection Approaches and Strategies for Introductory Analysis and Intervention Planning

Presenter: John A. Schneider MD, MPH, PhD

Associate Professor, Medicine and Epidemiology

Director, Chicago Center for HIV Elimination

Department of Medicine | Department of Public Health Sciences

University of Chicago

Abstract: I will be reviewing network data collection approaches and strategies for different types of introductory analysis and intervention planning.  If people can bring some of their network projects I could provide advice and support as well.

2:00pm-4:00pm. 2nd Floor – Room 3700, Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94143

Tuesday, May 17th, 2016

CAPS Town Hall presents John Schneider, MD, MPH: Network Interventions for HIV Elimination in the United States

John Schneider, MD, MPH, is an infectious disease specialist and network epidemiologist in the Departments of Medicine and Public Health Sciences at the University of Chicago.  He is also Director of the University of Chicago Center for HIV Elimination (http://hivelimination.uchicago.edu/).

Clinically, he specializes in HIV prevention and has a specific interest in the provision of high-quality care to younger Black men who have sex with men and transgender women.  He has extensive experience with advancing the physician patient relationship in resource restricted settings, including his current clinic at a Federally Qualified Health Center on the South Side of Chicago and during his time working in Southern India.

Dr. Schneider’s research focuses on how social networks can be leveraged to improve the health of at risk populations in resource restricted settings.

12:00pm-1:00pm. 3rd Floor – Room 3700, Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94143

John Schneider at a speaker podium speaking

Tuesday, May 3rd, 2016

CAPS eHealth Town Hall presents Josh Stein: AdhereTech’s smart pill bottles to track & improve adherence in real time

AdhereTech (AdhereTech.com) makes patented smart pill bottles designed to automatically track and analyze adherence in real time. If doses are missed, patients can receive customizable alerts and interventions – using automated phone calls, text messages, and more. AdhereTech’s smart pill bottles have been used by top healthcare institutions since 2013, including The Mount Sinai Health System, The Dana Farber Cancer Institute, Cincinnati Children’s Hospital, and others. AdhereTech smart bottles are being studied for their potential to increase adherence and duration on therapy.

Josh Stein is the CEO & Cofounder of AdhereTech. Josh has been a featured speaker at TEDMED, The National Institute of Health, HIMSS, Stanford Medicine X, and The Armada Specialty Pharmacy Summit. Josh has an MBA from Wharton and a BA from Washington University in St. Louis.

12:00pm-1:00pm. 3rd Floor – Room 3700, Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94143

Josh Stein, CEO an Co-Founder of Adhere Tech, with open arm and hand gesture at a TED Med talk

Wednesday, April 20th, 2016

CAPS Town Hall presents Dr. Valerie Jenness: Feminization of Trans Women in Prisons for Men: How An Alpha Male Total Institution Shapes Gender

Valerie Jenness is a Professor in the Department of Criminology, Law and Society and in the Department of Sociology at the University of California, Irvine. Her research focuses on the links between deviance and social control, the politics of crime control, social movements and social change, and transformations in corrections and public policy. She is the author of four books, including, most recently, Appealing to Justice: Prisoners, Grievances, and the Carceral Logic in the Post-Civil Rights Era (with Kitty Calavita, University of California Press, 2015) and many articles published in sociology, law, and criminology journals. Her work has been honored with awards from the American Sociological Association, the Society for the Study of Social Problems, the Pacific Sociological Association, the Law and Society Association, the Western Society of Criminology, University of California, and Gustavus Myers Center for the Study of Bigotry and Human Rights in North America.

Her studies of sexual assault in prisons, the management of prisoners with mental health concerns, transgender prisoners, and the inmate appeals system in prison have broken new ground and informed public policy. In addition, she has served on the Governor’s Rehabilitation Strike Team to assist with the implementation of legislation designed to provide rehabilitation services to tens of thousands of California prisoners (AB 900). More recently, she has worked with the Los Angeles Police Department and the U.S. Immigration and Customs Enforcement to develop and implement innovative policy related to the management and care of transgender prisoners.

12:00pm-1:00pm. 2nd Floor – Room 2700, Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94143

Tuesday, April 19th, 2016

CAPS eHealth Town Hall presents Fiona Smythe: Applications of Mobile Pharmacy Technology in HIV Research

Fiona will discuss how texting and mobile apps are being used at pharmacies across the country to help patients with chronic disease stay adherent to their medications. She will provide a brief demonstration of the mscripts mobile application, and then discuss the potential uses of mobile technology to reach out to and better understand targeted populations, such as patients with HIV. She will present research on medication adherence in an HIV population, conducted with Avella Specialty Pharmacy, as well as more recent data from texting outreach programs. We’ll save time at the end of the meeting to discuss potential opportunities for research using mobile pharmacy technology.

About mscripts: mscripts helps pharmacy patients manage their medications and adherence through an easy-to-use mobile and web health management platform. Pharmacies provide their patients with white-labeled versions of mscripts’ mobile applications, websites, and 2-way interactive SMS messaging, enabling them to refill, receive reminders to fill and take medications, and receive information related to their prescriptions. mscripts improves adherence by providing reminders, education, health information, and cost savings, and applying advanced analytics to better understand patient behavior. The mscripts’ platform serves millions of patients at national, regional and specialty pharmacies along with hospital out-patient systems. More information is available at www.mscripts.com.

12:00pm-1:00pm. 3rd Floor – Room 3500, Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94143

Monday, March 28th, 2016

2016 Annual CFAR Scientific Symposium: “Advancements and Challenges in PrEP”

UCSF-Gladstone Center for AIDS Research
Annual Scientific Symposium:
“Advancements and Challenges in PrEP”

Register here: http://cfar.ucsf.edu/cfar-scientific-symposium-registration-form

8:00AM-4:30pm. Mission Bay Conference Center, Roberston Auditorium, 1675 Owens Street, San Francisco, CA 94158

Tuesday, March 22nd, 2016

CAPS Town Hall presents Sebastian Kevany – Global Health Diplomacy: New Roles for the 21st Century

Diplomatic program alignment makes global health programs ‘smart’, or multifariously effective.  Such programs have the capacity to generate a range of ‘collateral’, downstream, indirect, or hidden benefits from the diplomatic perspective.  Similarly, programs need to be carefully aligned with principles of diplomacy in order to ensure that international relations goals are represented in intervention design, selection, & delivery, through awareness of cultural, religious, and social sensibilities.

Sebastian Kevany has conducted over 100 missions to Africa, the Middle East, and South-East Asia, with a particular focus on conflict and post-conflict settings, conducting program evaluation, diplomatic alignment, and other representative duties.  Sebastian holds BA and MA degrees from Trinity College Dublin, an MPH degree from the University of Cape Town, and is an international policy specialist at the University of California, San Francisco.

12:00pm-1:00pm. McKusick Conference Room (Room 3700), Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94158

Tuesday, March 15th, 2016

CAPS Town Hall presents Drs. Nguyen & Khalili – Multilingual mobile application to promote healthy behaviors among Asian Americans

Drs. Tung Nguyen and Mandana Khalili will present their Patient-Centered Outcomes Research Institute (PCORI) funded project to develop an interactive mobile application to promote screening for hepatitis B and C among at-risk Asian Americans who speak English, Cantonese, Mandarin, or Vietnamese. They will discuss the processes involved in developing the application and the lessons learned.

Dr. Nguyen is the Stephen J. McPhee, MD Endowed Chair in General Internal Medicine and Professor of Medicine at UCSF, where he provides primary care to a diverse patient population and teaches students, clinicians, and researchers.

Dr Khalili is Chief of Clinical Hepatology at SFGH, Assistant Director of the CTSI Comprehensive Mentoring Program Unit, and Director of the CTSI Mentor Consultation Services.

12:00pm-1:00pm. McKusick Conference Room (Room 3700), Mission Hall, 550 16th Street, 3rd floor, San Francisco, CA 94158

Friday, March 11th, 2016

CAPS Methods Core presents Dr. Jitendra Ganju – Making Clinical Trials Results Robust

This talk proposes a way to make inferences robust.  The idea is akin to how financial investments are made. Investment in a single stock, which is analogous to pre-specifying a single analysis method, is unwise.  A better way is to hedge our bets. This means pre-specifying a combining function for multiple pre-specified test statistics for formal inference. The versatility of the combination method is manifold: inferences are robust; the combined test statistic can yield more power than the best performing single test; it can be used when the number of covariates exceeds the number of observations; in group sequential trials, the set of tests at one interim analysis may be different from that at another interim, making analyses more flexible; it permits simultaneous rejection of the null in an overall sample and in subgroups. The recommendation is to replace the practice of relying exclusively on a single test with multiple tests.  Open areas for more research will be noted.

Jitendra Ganju, PhD is VP of Biometrics at Global Blood Therapeutics, a biopharmaceutical company based in South San Francisco. Currently, I’m working with teams within GBT on planning trials for potential treatments for sickle cell disease and idiopathic lung fibrosis.  In past decade I’ve also worked at Amgen, Gilead Sciences, and Hyperion Therapeutics.  My entire 20+ year career since the completion of my dissertation has been in the pharma / biotech industry. I received my PhD in Statistics from the University of Delaware.  My dissertation topic was on inherently restricted randomized trials that are inadvertently treated as fully randomized experiments.  I’ve served as Associate Editor of Controlled Clinical Trials (now Contemporary Clinical Trials).  Some of my published work includes topics such as inference from blinded data, stratification in clinical trials, increasing power by combining tests statistics testing the same hypothesis, bias in tests when randomization restrictions are caused by not re-setting factor levels.  My research interests include multiple comparisons, and making clinical trial designs and inferences robust.

The CAPS Methods Core activity can now be checked directly on the website:

http://caps.ucsf.edu/about/structure-cores/methods-core/

Materials from past Methods Core seminars can be found at

http://caps.ucsf.edu/about/structure-cores/methods-core/methods-core-seminars/

Friday, 3/11/2016 @ 10:00am-11:30am

McKusick Conference Room (Room 3700)
Mission Hall, 550 16th Street, 3rd floor
San Francisco, CA 94158